Antidepressants lower libido primarily by flooding the brain with serotonin, which in turn suppresses dopamine, the chemical most responsible for desire, pleasure, and sexual motivation. This isn’t a rare side effect or a sign something is wrong with you. It’s a predictable consequence of how the most commonly prescribed antidepressants work. The effect is strongest with SSRIs and SNRIs, the two classes doctors reach for most often.
Serotonin Suppresses the Brain’s Reward System
SSRIs work by blocking serotonin from being reabsorbed after it’s released, leaving more of it active in the brain. That extra serotonin helps with depression and anxiety, but it also puts the brakes on dopamine signaling in the brain’s sexual circuits. Dopamine is the neurotransmitter behind wanting, craving, and feeling rewarded. When serotonin dampens dopamine activity, your brain’s motivation for sex drops. This isn’t subtle. It can affect desire, arousal, and the ability to reach orgasm all at once.
Research confirms that antidepressants increasing serotonin through transporter blockade are the ones that cause sexual problems, while those that primarily boost dopamine and norepinephrine don’t. Importantly, just adding norepinephrine activity on top of the serotonin increase doesn’t fix the problem. You need dopamine restoration specifically. This is why switching to or adding a dopamine-active medication is one of the more effective solutions.
What Happens in the Body, Not Just the Brain
The effects aren’t limited to your brain chemistry. SSRIs also interfere with blood flow to the genitals. Arousal, erections in men and engorgement in women, depends on nitric oxide, a molecule that relaxes blood vessels and increases circulation to sexual tissue. Animal studies on escitalopram (Lexapro) found that the drug didn’t reduce the body’s production of nitric oxide directly. Instead, it ramped up an enzyme that generates reactive oxygen species, effectively destroying nitric oxide before it could do its job. The result was measurably reduced erectile response after just 30 days of treatment.
Research on paroxetine (Paxil) found a slightly different mechanism, with the drug appearing to reduce nitric oxide production more directly. Either way, the outcome is the same: less blood flow, weaker physical arousal, and reduced genital sensation. This physical component explains why some people on SSRIs feel mentally interested in sex but find their body simply doesn’t respond.
Prolactin: A Hormonal Layer
There’s a third mechanism at work. Nearly all antidepressants can raise levels of prolactin, a hormone best known for its role in milk production but also a powerful suppressant of sexual desire. Serotonin triggers prolactin release through an indirect chain reaction: it stimulates certain neurons that inhibit dopamine’s usual job of keeping prolactin in check. With that control removed, prolactin levels climb.
Elevated prolactin causes a recognizable cluster of symptoms beyond low libido, including menstrual irregularities, breast tenderness, and in some cases, difficulty with fertility. SSRIs and the tricyclic antidepressant clomipramine carry the highest risk. One analysis found serotonergic antidepressants were associated with nearly 13 times the odds of elevated prolactin compared to people not taking antidepressants. Mirtazapine is the only antidepressant convincingly shown not to raise prolactin levels.
Not All Antidepressants Are Equal
The sexual side effects concentrate heavily in the SSRI class (fluoxetine, sertraline, paroxetine, escitalopram, citalopram) and SNRIs (venlafaxine, duloxetine). But several antidepressants cause little to no sexual dysfunction compared to placebo:
- Bupropion (Wellbutrin) works on dopamine and norepinephrine rather than serotonin. Head-to-head trials found it caused significantly less sexual dysfunction than sertraline or fluoxetine. The American Academy of Family Physicians calls it the best option for patients concerned about sexual side effects.
- Mirtazapine (Remeron) blocks specific serotonin receptors involved in sexual suppression rather than flooding the system with serotonin broadly. The tradeoff is a relatively high rate of weight gain and sedation.
- Vilazodone and agomelatine also show minimal sexual side effects in clinical trials compared to placebo.
What You Can Do About It
If you’re already on an SSRI and experiencing sexual side effects, there are several practical approaches. Dose reduction is typically tried first because it’s the least disruptive to your mental health treatment. Even a modest decrease can sometimes restore sexual function while still managing depression effectively.
Adding bupropion alongside your current SSRI has the strongest evidence behind it. In one study, bupropion reversed sexual dysfunction in 66% of patients, improving desire, arousal, and orgasm. Doses of 150 to 300 mg of the extended-release form are what’s typically used. This is one of the most common strategies in practice because it lets you keep the antidepressant that’s working for your mood while directly counteracting the dopamine suppression causing the sexual problems.
For arousal and erectile difficulties specifically, medications that increase blood flow to the genitals have demonstrated clear benefit in men on SSRIs. Evidence in women is more preliminary but exists. These work by boosting nitric oxide activity, directly addressing the vascular mechanism described earlier.
Non-drug approaches also have supporting evidence. Exercise before sexual activity significantly increased arousal in women taking SSRIs in one trial. Yoga has shown benefits in open-label studies. These options are worth trying alongside or before medication changes.
When Sexual Side Effects Persist After Stopping
For most people, sexual function returns after discontinuing the antidepressant. But a subset of people experience what’s now formally recognized as Post-SSRI Sexual Dysfunction (PSSD), where symptoms persist for months or years after stopping the medication. Diagnostic criteria were established by a panel that included researchers from Weill Cornell Medicine. The hallmark features include reduced genital and orgasmic sensation, decreased desire, and erectile dysfunction. Some people also experience emotional blunting and cognitive changes.
PSSD remains poorly understood and has no established treatment. Its existence is increasingly recognized in the medical literature, though the exact prevalence is still unknown. It doesn’t happen to most people who take SSRIs, but it’s worth being aware of, particularly if you’re weighing whether to start one.